In fact, the composition of CSF is not fixed and changes dynamically under neuropathological conditions, such as the occurrence Aβ of and tau protein in Alzheimer’s disease (AD) and the enrichment of α-synuclein in Parkinson’s disease [22–27]. This evidence concerns the gene MAPT and Parkinson disease.